Novel theranostic approach for treating pancreatic cancer patients shows promise

by Society of Nuclear Medicine and Molecular Imaging(A)18FDG PET before177Lu-3BP-227 therapy. Red oval: primary tumor; arrows: liver metastases. (B, upper panel) Axial CT section; primary

Updated on: April 09,2024 15

Novel theranostic approach for treating pancreatic cancer patients shows promise

by Society of Nuclear Medicine and Molecular Imaging(A)18FDG PET before177Lu-3BP-227 therapy. Red oval: primary tumor; arrows: liver metastases. (B, upper panel) Axial CT section; primary

Updated on:April 09,2024 15

Study finds large gap in breast cancer treatment recommendations for patients aged 70 vs. 69

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainAge-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic

Updated on: January 23,2024 15

Study finds large gap in breast cancer treatment recommendations for patients aged 70 vs. 69

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainAge-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic

Updated on:January 23,2024 15

Smart bomb virus shows promise as brain tumor immunotherapy

by University of Texas M. D. Anderson Cancer CenterCredit: Min Yu (Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC),USC Norris Comprehensive Cancer CenterA com

Updated on: April 09,2024 10

Smart bomb virus shows promise as brain tumor immunotherapy

by University of Texas M. D. Anderson Cancer CenterCredit: Min Yu (Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC),USC Norris Comprehensive Cancer CenterA com

Updated on:April 09,2024 10

FDA Approves Two Cell-Based SCD Gene Therapies

February 2024The U.S. Food and Drug Administration (FDA) approved exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel) for the treatment of sickle cell disease (SCD) in patient

Updated on: February 18,2024 6

FDA Approves Two Cell-Based SCD Gene Therapies

February 2024The U.S. Food and Drug Administration (FDA) approved exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel) for the treatment of sickle cell disease (SCD) in patient

Updated on:February 18,2024 6

Team introduces new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction

byHelmholtz Zentrum MünchenFSP1 condensates in green induced by icFSP1 surrounding a blue nucleus. Credit: Toshitaka NakamuraA team of researchers led by Dr. Marcus Conrad from Helmholtz Munich

Updated on: January 08,2024 15

Team introduces new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction

byHelmholtz Zentrum MünchenFSP1 condensates in green induced by icFSP1 surrounding a blue nucleus. Credit: Toshitaka NakamuraA team of researchers led by Dr. Marcus Conrad from Helmholtz Munich

Updated on:January 08,2024 15

An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

by The University of Hong KongGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111647A research team from the LKS Faculty of Medicine, the University of Hong

Updated on: January 30,2024 17

An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

by The University of Hong KongGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111647A research team from the LKS Faculty of Medicine, the University of Hong

Updated on:January 30,2024 17

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

Updated on: April 12,2024 15

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

Updated on:April 12,2024 15

Bladder cancer treatment can be better targeted and more effective, trials show

by European Association of UrologyCredit: Unsplash/CC0 Public DomainTesting for tumor DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following su

Updated on: April 06,2024 0

Bladder cancer treatment can be better targeted and more effective, trials show

by European Association of UrologyCredit: Unsplash/CC0 Public DomainTesting for tumor DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following su

Updated on:April 06,2024 0

New drug could be advance against glioma brain tumors

by Dennis ThompsonAn experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds.The oral drug vorasidenib nearly tripled progress

Updated on: February 18,2024 17

New drug could be advance against glioma brain tumors

by Dennis ThompsonAn experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds.The oral drug vorasidenib nearly tripled progress

Updated on:February 18,2024 17

Study could help explain why certain brain tumors don't respond well to immunotherapy

by University of California, Los AngelesCredit: Unsplash/CC0 Public DomainA study led by researchers at the UCLA Jonsson Comprehensive Cancer Center sheds new light on why tumors that have spread

Updated on: February 18,2024 15

Study could help explain why certain brain tumors don't respond well to immunotherapy

by University of California, Los AngelesCredit: Unsplash/CC0 Public DomainA study led by researchers at the UCLA Jonsson Comprehensive Cancer Center sheds new light on why tumors that have spread

Updated on:February 18,2024 15

Regorafenib shown to augment antitumor effect of anti-PD-1 immunotherapy in advanced gastric cancers

byKumamoto UniversityCredit:Cancer Research(2022). DOI: 10.1158/0008-5472.CAN-22-1890Fibrotic cancers such as gastric cancers are highly resistant to conventional therapies like immu

Updated on: January 03,2024 8

Regorafenib shown to augment antitumor effect of anti-PD-1 immunotherapy in advanced gastric cancers

byKumamoto UniversityCredit:Cancer Research(2022). DOI: 10.1158/0008-5472.CAN-22-1890Fibrotic cancers such as gastric cancers are highly resistant to conventional therapies like immu

Updated on:January 03,2024 8

Researchers expanding the types of cancer CAR-T therapy can target

by Gregory Allen,The ConversationKiller T cells (green and red), or cytotoxic T cells, surround a cancer cell (blue, center). Credit:NICHD/J. Lippincott-Schwartz,CC BY-NC-NDTeaching

Updated on: February 23,2024 13

Researchers expanding the types of cancer CAR-T therapy can target

by Gregory Allen,The ConversationKiller T cells (green and red), or cytotoxic T cells, surround a cancer cell (blue, center). Credit:NICHD/J. Lippincott-Schwartz,CC BY-NC-NDTeaching

Updated on:February 23,2024 13